Stéphane Bancel, AP Images
August 10, 2021 08:58 AM EDTUpdated August 13, 03:59 PM
Bioregnum
Pharma

Mod­er­na soars in­to the ranks of the world's top phar­ma play­ers, now worth 3 Re­gen­erons

As we got start­ed this morn­ing, there was quite a bit of in­ter­est in see­ing if Mod­er­na could break the $200 bil­lion mark to­day on …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Lil­ly shuf­fles key ex­ec­u­tive po­si­tions; Mikael Dol­sten takes an­oth­er post-Pfiz­er as­sign­ment

Rev­o­lu­tion’s KRAS drugs ap­pear com­pet­i­tive in sev­er­al lung can­cer set­tings

Corvus' ear­ly-phase atopic der­mati­tis da­ta prompt stock ral­ly

As­traZeneca re­ports Phase 3 win for Imfinzi; Roche to build new man­u­fac­tur­ing site in Chi­na

AI biotech In­sil­i­co Med­i­cine goes for third at­tempt at Hong Kong IPO

sponsored

In one of the riski­est in­dus­tries — Biotech — a sure­fire way to neu­tral­ize some of that risk emerges

A service from the Financial Times